DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c54850) has announced the addition of "OTC Healthcare in Belarus" to their offering.
Our OTC Healthcare Products in Belarus report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. Forecasts to 2010 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares and brand shares
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Smoking cessation aids see strongest performance
There is a longstanding tradition of smoking in Belarus, particularly among men. However, in more recent times initiatives by the government to curb smoking, such as educational campaigns informing consumers of the dangers of tobacco, have stimulated demand for NRT smoking cessation aids. As a result these products saw the most dynamic performance in the country's OTC healthcare market in 2005.
Lower growth in 2005 as government tackles inflation
While continuing to see notable growth throughout the OTC healthcare market in 2005, the increase seen in Belarus in current value terms was lower than the previous year, continuing the trend seen throughout the review period. This was due to efforts by the country's government to combat inflation. In constant value terms the majority of products saw declines in 2005.
Distribution limitations a key factor
The government in Belarus maintains a firm grip on the country's OTC healthcare industry, with the sale of such products only allowed through chemist outlets. No OTC healthcare products are available through other channels, such as supermarkets and hypermarkets or convenience stores. As a result of this policy there are no private label OTC healthcare products in the country. As a result price-sensitive consumers stick to purchases of low-priced products from local manufacturers.
-Borisov Plant of Medical Preparations
For more information, visit http://www.researchandmarkets.com/reports/c54850
Source: Euromonitor International